Evercore

Cognex to Acquire RealSense for $500M, Enters Robotic Perception Market

Cognex to Acquire RealSense for $500M, Enters Robotic Perception Market

Natick, Mass. – September 22, 2026 -- Cognex Corporation (NASDAQ: CGNX) has agreed to acquire RealSense, the market leader in depth-sensing cameras for robotic perception and Physical AI, for approximately $500 million in cash, the company announced. The deal, financed entirely from Cognex's existing cash and investments, is expected to close in the fourth quarter of 2026 subject to customary conditions.

RealSense revenue is set to grow more than 50% to $80-90 million in 2026

RealSense, originally founded by Intel in 2014 and spun out as an independent company in 2025, is projected to generate $80 million to $90 million in revenue this year, representing growth of more than 50% over the prior year. The company's 3D perception technology serves fixed-arm robotics, autonomous mobile robots, quadrupeds and humanoids.

Labcorp Acquires MLM Medical Labs, Gains Four-Continent Lab Network

Labcorp Acquires MLM Medical Labs, Gains Four-Continent Lab Network

Burlington, N.C. – September 11, 2026 -- Labcorp (NYSE: LH) has acquired MLM Medical Labs, a central and specialty laboratory provider with operations in the United States, Germany and South Africa, financial terms undisclosed.

Labcorp becomes the only central lab provider with wholly owned facilities on four continents

The deal extends Labcorp's laboratory footprint across North America, Europe, Asia and Africa, combining its global scale with MLM's regional laboratory network and biomarker testing capabilities. The transaction strengthens Labcorp's position as an independent central laboratory services provider for clinical trial sponsors.